tailieunhanh - Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: Initial experience of molecularly targeted therapy

Although tenosynovial giant cell tumor (TGCT) is classified as a benign tumor, it may undergo malignant transformation and metastasize in extremely rare occasions. High aberrant expression of CSF1 has been implicated in the development of TGCT and recent studies have shown promising activity of several CSF1R inhibitors against benign diffuse-type TGCT; however, little is known about their effects in malignant TGCT. | Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor Initial experience of molecularly targeted therapy

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN